REBEKAH TUCKER: Open Payments
NPI 1265196869 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 69 payments from 13 companies in 2025. Trend: 2023 $691 · 2024 $1,226 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $257 |
| AstraZeneca Pharmaceuticals LP | 13 | $253 |
| Novo Nordisk Inc | 10 | $167 |
| PFIZER INC. | 6 | $127 |
| Dexcom, Inc. | 5 | $86 |
| Lilly USA, LLC | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $58 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Amgen Inc. | 2 | $29 |
| Medtronic, Inc. | 1 | $25 |
Products named: FARXIGA, UBRELVY, Dexcom G6 Transmitter, Wegovy, MOUNJARO, Ozempic, NURTEC ODT, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
